BioMarin Pharmaceutical Inc. (BMRN.OQ)

BioMarin Pharmaceutical Inc. (BMRN.OQ) Trading on MT5 at XM

At XM we offer BioMarin Pharmaceutical Inc. (BMRN.OQ) stocks as cash CFDs. Our cash CFDs stocks are undated transactions that aim to replicate the cash price of the underlying stock, and so they are adjusted for any relevant corporate actions.

Open a Demo Account
Open an Account

Risk warning: FX and CFD trading involves a high risk of loss.

About BioMarin Pharmaceutical Inc. (BMRN.OQ) Trading

BioMarin Pharmaceutical Inc. is a multinational biotechnology company that manufactures a wide range of pharmaceuticals used for the treatment of rare diseases. The company was founded in 1997 and has its headquarters in San Rafael, California, USA. BioMarin Pharmaceutical is a NASDAQ-100 component, and its stock is traded on Nasdaq.

Trading Conditions

Margin requirement 10 %
Spreads as low as 0.76
Symbols Biomarin
Description Biomarin Pharmaceutical Inc
Min. Price Fluctuation 0.01000
Value of Minimum Price Fluctuation USD 0.1
Value of 1 lot 10 Shares
Min/Max Trade Size 0.6/82
Swap Value in Margin Currency Long -3.2 %
Swap Value in Margin Currency Short -2.8 %
Limit and Stop Levels** 0.05
Total Volume Limit (per client)*** 823
Weekday 16:40-22:55 (GMT +3)
Monday Open 16:40 (GMT +3)   │   Friday Close 22:55 (GMT +3)
** Min. level for placing pending orders at a current market price.

*** Note that the maximum trading volume for Biomarin per client is 823 lots. This limit will be reviewed on a daily basis and updated according to the value of the instrument.

How to Start Trading BioMarin Pharmaceutical Inc. (BMRN.OQ)?

Step 1

Open an XM Real Account

Step 2

Download and login to the MT5 platform

Step 3

Double-click on BioMarin Pharmaceutical Inc. (BMRN.OQ) from the “Market Watch” to open an order for this instrument.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.